Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

A Novel Regulatory Axis, CHD1L-MicroRNA 486-Matrix Metalloproteinase 2, Controls Spermatogonial Stem Cell Properties.

Liu SS, Maguire EM, Bai YS, Huang L, Liu Y, Xu L, Fauzi I, Zhang SQ, Xiao Q, Ma NF.

Mol Cell Biol. 2019 Feb 4;39(4). pii: e00357-18. doi: 10.1128/MCB.00357-18. Print 2019 Feb 15.

PMID:
30455250
2.

Foam cell formation: A new target for fighting atherosclerosis and cardiovascular disease.

Maguire EM, Pearce SWA, Xiao Q.

Vascul Pharmacol. 2018 Aug 13. pii: S1537-1891(18)30108-3. doi: 10.1016/j.vph.2018.08.002. [Epub ahead of print] Review.

PMID:
30115528
3.

Genetic and Pharmacologic Inhibition of the Neutrophil Elastase Inhibits Experimental Atherosclerosis.

Wen G, An W, Chen J, Maguire EM, Chen Q, Yang F, Pearce SWA, Kyriakides M, Zhang L, Ye S, Nourshargh S, Xiao Q.

J Am Heart Assoc. 2018 Feb 8;7(4). pii: e008187. doi: 10.1161/JAHA.117.008187.

4.

miR-22 Is a Novel Mediator of Vascular Smooth Muscle Cell Phenotypic Modulation and Neointima Formation.

Yang F, Chen Q, He S, Yang M, Maguire EM, An W, Afzal TA, Luong LA, Zhang L, Xiao Q.

Circulation. 2018 Apr 24;137(17):1824-1841. doi: 10.1161/CIRCULATIONAHA.117.027799. Epub 2017 Dec 15.

5.

Cbx3 inhibits vascular smooth muscle cell proliferation, migration, and neointima formation.

Zhang C, Chen D, Maguire EM, He S, Chen J, An W, Yang M, Afzal TA, Luong LA, Zhang L, Lei H, Wu Q, Xiao Q.

Cardiovasc Res. 2018 Mar 1;114(3):443-455. doi: 10.1093/cvr/cvx236.

PMID:
29206900
6.

Novel Pathological Role of hnRNPA1 (Heterogeneous Nuclear Ribonucleoprotein A1) in Vascular Smooth Muscle Cell Function and Neointima Hyperplasia.

Zhang L, Chen Q, An W, Yang F, Maguire EM, Chen D, Zhang C, Wen G, Yang M, Dai B, Luong LA, Zhu J, Xu Q, Xiao Q.

Arterioscler Thromb Vasc Biol. 2017 Nov;37(11):2182-2194. doi: 10.1161/ATVBAHA.117.310020. Epub 2017 Sep 14.

7.

Differentiation and Application of Induced Pluripotent Stem Cell-Derived Vascular Smooth Muscle Cells.

Maguire EM, Xiao Q, Xu Q.

Arterioscler Thromb Vasc Biol. 2017 Nov;37(11):2026-2037. doi: 10.1161/ATVBAHA.117.309196. Epub 2017 Aug 31. Review.

PMID:
28860223
8.

Evaluating the implementation of a national disclosure policy for large-scale adverse events in an integrated health care system: identification of gaps and successes.

Maguire EM, Bokhour BG, Wagner TH, Asch SM, Gifford AL, Gallagher TH, Durfee JM, Martinello RA, Elwy AR.

BMC Health Serv Res. 2016 Nov 11;16(1):648.

9.

Disclosing large scale adverse events in the US Veterans Health Administration: lessons from media responses.

Maguire EM, Bokhour BG, Asch SM, Wagner TH, Gifford AL, Gallagher TH, Durfee JM, Martinello RA, Elwy AR.

Public Health. 2016 Jun;135:75-82. doi: 10.1016/j.puhe.2015.10.016. Epub 2016 Mar 26.

PMID:
27026251
10.

Improving healthcare systems' disclosures of large-scale adverse events: a Department of Veterans Affairs leadership, policymaker, research and stakeholder partnership.

Elwy AR, Bokhour BG, Maguire EM, Wagner TH, Asch SM, Gifford AL, Gallagher TH, Durfee JM, Martinello RA, Schiffner S, Jesse RL.

J Gen Intern Med. 2014 Dec;29 Suppl 4:895-903. doi: 10.1007/s11606-014-3034-3.

Supplemental Content

Loading ...
Support Center